文献检索，用中文搜 PubMed

1

Retraction notice to "Pulmonary route of administration is instrumental in developing therapeutic interventions against respiratory diseases" [Saudi Pharm. J. 28(12) (2020) 1655-1665].撤回声明：“肺部给药途径对开发呼吸系统疾病治疗干预措施具有重要作用”[《沙特药学杂志》28(12) (2020) 1655 - 1665]

Saudi Pharm J. 2022 May;30(5):646. doi: 10.1016/j.jsps.2022.04.011. Epub 2022 May 11.

2

Retraction notice to "The influence of connective tissue growth factor on rabbit ligament injury repair" [Saudi Pharm. J. 25 (2017) 498-503].撤回通知：“结缔组织生长因子对兔韧带损伤修复的影响”[《沙特药学杂志》25 (2017) 498 - 503]

Saudi Pharm J. 2020 May;28(5):637. doi: 10.1016/j.jsps.2020.02.012. Epub 2020 May 12.

3

Retraction notice to "Biomedical microelectromechanical systems (BioMEMS): Revolution in drug delivery and analytical techniques" [Saudi Pharm. J. 24 (2016) 1-20].撤回通知：“生物医学微机电系统（BioMEMS）：药物递送与分析技术的革命”[《沙特药学杂志》24（2016年）1 - 20页]

Saudi Pharm J. 2019 Mar;27(3):453. doi: 10.1016/j.jsps.2019.03.003. Epub 2019 Mar 13.

4

Retraction notice to "The cytoprotective effects of Δ-17 fatty acid desaturase on injured HUVECs and its underlying mechanism" [Saudi Pharm. J. 25(4) (2017) 587-594].撤回通知：“Δ-17脂肪酸去饱和酶对受损人脐静脉内皮细胞的细胞保护作用及其潜在机制”[《沙特药学杂志》25(4) (2017) 587 - 594]

Saudi Pharm J. 2022 May;30(5):647. doi: 10.1016/j.jsps.2022.04.010. Epub 2022 May 11.

5

Retraction notice to "Melatonin alleviates acute spinal cord injury in rats through promoting on progenitor cells proliferation" [Saudi Pharm. J. 25 (2017) 570-574].撤回通知：“褪黑素通过促进祖细胞增殖减轻大鼠急性脊髓损伤”[《沙特药学杂志》25(2017)570 - 574]

Saudi Pharm J. 2020 May;28(5):638. doi: 10.1016/j.jsps.2020.02.013. Epub 2020 May 12.

6

Retraction notice to "The comparative study of clinical efficacy and safety of baclofen vs tolperisone in spasticity caused by spinal cord injury" [Saudi Pharm. J. 25 (2017) 655-659].撤回通知：“巴氯芬与托哌酮治疗脊髓损伤所致痉挛的临床疗效与安全性的比较研究”[《沙特药学杂志》25 (2017) 655 - 659]

Saudi Pharm J. 2020 May;28(5):639. doi: 10.1016/j.jsps.2020.02.014. Epub 2020 May 12.

7

Retraction notice to "Protective effect of Huangpu Tongqiao capsule against Alzheimer's disease through inhibiting the apoptosis pathway mediated by endoplasmic reticulum stress and " [Saudi Pharm. J. 30(11) (2022) 1561-1571].撤回通知：“黄浦通窍胶囊通过抑制内质网应激介导的凋亡途径对阿尔茨海默病的保护作用”[《沙特药学杂志》30(11) (2022) 1561 - 1571]

Saudi Pharm J. 2024 Nov;32(11):102183. doi: 10.1016/j.jsps.2024.102183. Epub 2024 Sep 21.

8

Retraction notice to "A DNA-based nanocarrier for efficient cancer therapy" [J. Pharm. Anal. 11 (2021) 330-339].对《一种用于高效癌症治疗的基于DNA的纳米载体》[《药物分析杂志》11 (2021) 330 - 339]的撤稿通知。

J Pharm Anal. 2021 Jun;11(3):R1. doi: 10.1016/j.jpha.2024.100963. Epub 2024 Mar 19.

9

Retraction notice to "Choroidal osteoma with CNVM - Successful treatment with intravitreal Bevacizumab" [Saudi J Ophthalmol 25 (2011) 199-202].撤稿通知：“伴有脉络膜新生血管的脉络膜骨瘤——玻璃体内注射贝伐单抗成功治疗”[《沙特眼科杂志》25（2011年）199 - 202页]

Saudi J Ophthalmol. 2018 Oct-Dec;32(4):360. doi: 10.1016/j.sjopt.2018.12.003. Epub 2018 Dec 19.

10

Corrigendum to "Medication safety practices in hospitals: A national survey in Saudi Arabia" [Saudi Pharm. J. 21(2) (2013) 159-164].勘误：“沙特阿拉伯全国医院用药安全实践调查”[沙特药学杂志 21(2)（2013）159-164]。

Saudi Pharm J. 2016 Mar;24(2):232. doi: 10.1016/j.jsps.2015.04.001. Epub 2015 Apr 24.

Suppr 超能文献

文献检索

文件翻译

深度研究

Suppr 超能文献

文献检索

文件翻译

深度研究

撤回声明：“肺部给药途径对开发呼吸系统疾病治疗干预措施具有重要作用”[《沙特药学杂志》28(12) (2020) 1655 - 1665]

Retraction notice to "Pulmonary route of administration is instrumental in developing therapeutic interventions against respiratory diseases" [Saudi Pharm. J. 28(12) (2020) 1655-1665].

作者信息

机构信息

出版信息